44 research outputs found

    Π‘Ρ€Π°Π²Π½ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ ΠΎΡ†Π΅Π½ΠΊΠ° Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚ΠΎΠ² измСрСния Смкости Π²Π΄ΠΎΡ…Π° с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ΠΏΠΎΠ±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ спиромСтра ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Π° ΡƒΠ»ΡŒΡ‚Ρ€Π°Π·Π²ΡƒΠΊΠΎΠ²ΠΎΠΉ спирографии Π² Ρ€Π°Π½Π½Π΅ΠΌ послСопСрационном ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ Ρƒ кардиохирургичСских ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ²

    Get PDF
    Incentive spirometry is one of the most common methods used for respiratory rehabilitation in the early period after cardiac surgery. Inspiratory capacity values, obtained by a patient using spirometer, are not reliably trusted.Objectives. To compare volumetric parameters measured with incentive spirometer and results obtained with bedside ultrasound-based spirometer to assure the feasibility of the use of incentive spirometry to assess the inspiratory capacity and effectiveness of postoperative respiratory rehabilitation.Materials and methods. The study included 50 patients after elective cardiac surgery. Pulmonary rehabilitation involved the use of various respiratory therapy methods. Spirography was performed before and after each session. Both approaches were used simultaneously to obtain the spirometry maximum inspiratory capacity (SMIC) with a bedside ultrasonic spirography and maximum inspiratory capacity (MIC) index using an incentive spirometer. Patient’s discomfort and adverse events during the procedures were recorded.Results. The absolute values of the MIC measured before and after each session by the two methods were dissimilar, however, the average increment values (6) did not show statistically significant differences. The correlation analysis revealed a strong positive statistically significant relationship between 6 SMIC and 6 MIC (R = 0.74 before the session, R = 0.79 after the session, R = 0.77 across the whole data set, P < 0.01), also consistent with the Bland–Altman analysis, evidencing that more than 95% of all values fell within Β± 1.96 SD of the mean difference. The inspiratory spirometry method showed good diagnostic accuracy (sensitivity 87%, specificity 85%, area under the curve (AUC) 0.8 (95% CI: [0.76; 0.83]), P < 0.001). Refusals of procedure were more often documented with ultrasonic spirography.Conclusion. The increment in the inspiratory capacity index measured with incentive spirometer shows good agreement with ultrasonic spirography measurements. Therefore, incentive spirometry can be reliably used to assess the effectiveness of respiratory rehabilitation interventions in cardiac surgery patients during early postoperative period.ΠŸΠΎΠ±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ спиромСтрия относится ΠΊ Π½Π°ΠΈΠ±ΠΎΠ»Π΅Π΅ распространСнным ΠΌΠ΅Ρ‚ΠΎΠ΄Π°ΠΌ, примСняСмым для рСспираторной Ρ€Π΅Π°Π±ΠΈΠ»ΠΈΡ‚Π°Ρ†ΠΈΠΈ Π² Ρ€Π°Π½Π½ΠΈΠ΅ сроки послС кардиохирургичСских Π²ΠΌΠ΅ΡˆΠ°Ρ‚Π΅Π»ΡŒΡΡ‚Π². ΠŸΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€Π° основана Π½Π° ΡΠ°ΠΌΠΎΡΡ‚ΠΎΡΡ‚Π΅Π»ΡŒΠ½ΠΎΠΌ ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½ΠΈΠΈ объСма Π²Π΄ΠΎΡ…Π° ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠΌ, ΠΎΠ΄Π½Π°ΠΊΠΎ остаСтся нСясным, насколько ΠΌΠΎΠΆΠ½ΠΎ Π΄ΠΎΠ²Π΅Ρ€ΡΡ‚ΡŒ Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ этих ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½ΠΈΠΉ.  ЦСль исслСдования. Π‘Ρ€Π°Π²Π½ΠΈΡ‚ΡŒ Π²ΠΎΠ»ΡŽΠΌΠ΅Ρ‚Ρ€ΠΈΡ‡Π΅ΡΠΊΠΈΠ΅ ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΠΈ, ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½Π½Ρ‹Π΅ с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ΠΏΠΎΠ±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ спиромСтра с Π΄Π°Π½Π½Ρ‹ΠΌΠΈ ΠΏΡ€ΠΈΠΊΡ€ΠΎΠ²Π°Ρ‚Π½ΠΎΠΉ ΡƒΠ»ΡŒΡ‚Ρ€Π°Π·Π²ΡƒΠΊΠΎΠ²ΠΎΠΉ спиромСтрии ΠΈ ΠΎΡ†Π΅Π½ΠΈΡ‚ΡŒ Π²ΠΎΠ·ΠΌΠΎΠΆΠ½ΠΎΡΡ‚ΡŒ использования ΠΏΠΎΠ±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ спиромСтрии для ΠΎΡ†Π΅Π½ΠΊΠΈ Смкости Β Β Π²Π΄ΠΎΡ…Π° ΠΈ эффСктивности послСопСрационной рСспираторной Ρ€Π΅Π°Π±ΠΈΠ»ΠΈΡ‚Π°Ρ†ΠΈΠΈ.ΠœΠ°Ρ‚Π΅Ρ€ΠΈΠ°Π»Ρ‹ ΠΈ ΠΌΠ΅Ρ‚ΠΎΠ΄Ρ‹.Β  Π’ исслСдованиС вошли 50 ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² послС ΠΏΠ»Π°Π½ΠΎΠ²Ρ‹Ρ… кардиохирургичСских ΠΎΠΏΠ΅Ρ€Π°Ρ†ΠΈΠΉ. Π Π΅Π°Π±ΠΈΠ»ΠΈΡ‚Π°Ρ†ΠΈΡŽ ΠΏΡ€ΠΎΠ²ΠΎΠ΄ΠΈΠ»ΠΈ с использованиСм Ρ€Π°Π·Π»ΠΈΡ‡Π½Ρ‹Ρ… рСспираторных ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ². Π”ΠΎ ΠΈ послС ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ сСанса выполняли ΡΠΏΠΈΡ€ΠΎΠ³Ρ€Π°Ρ„ΠΈΡŽ с использованиСм ΠΏΡ€ΠΈΠΊΡ€ΠΎΠ²Π°Ρ‚Π½ΠΎΠ³ΠΎ ΡƒΠ»ΡŒΡ‚Ρ€Π°Π·Π²ΡƒΠΊΠΎΠ²ΠΎΠ³ΠΎ спиромСтра. ΠžΡ†Π΅Π½ΠΈΠ²Π°Π»ΠΈ ΠΌΠ°ΠΊΡΠΈΠΌΠ°Π»ΡŒΠ½ΡƒΡŽ Π΅ΠΌΠΊΠΎΡΡ‚ΡŒ Π²Π΄ΠΎΡ…Π° (Π‘ΠœΠ•Π’Π΄), ΠΎΠ΄Π½ΠΎΠ²Ρ€Π΅ΠΌΠ΅Π½Π½ΠΎ опрСдСляли Β ΠΏΠΎΠΊΠ°Π·Π°Ρ‚Π΅Π»ΡŒ максимальной Смкости Π²Π΄ΠΎΡ…Π° (ΠœΠ•Π’Π΄) с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ΠΏΠΎΠ±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ спиромСтра. РСгистрировали  Π½Π΅ΠΆΠ΅Π»Π°Ρ‚Π΅Π»ΡŒΠ½Ρ‹Π΅ явлСния ΠΈ дискомфорт ΠΏΡ€ΠΈ ΠΏΡ€ΠΎΠ²Π΅Π΄Π΅Π½ΠΈΠΈ ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€.Π Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Ρ‹. ΠΠ±ΡΠΎΠ»ΡŽΡ‚Π½Ρ‹Π΅ Π²Π΅Π»ΠΈΡ‡ΠΈΠ½Ρ‹ максимальной Смкости Π²Π΄ΠΎΡ…Π°, ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½Π½Ρ‹Π΅ Π΄ΠΎ ΠΈ послС ΠΊΠ°ΠΆΠ΄ΠΎΠ³ΠΎ сСанса с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ сравниваСмых ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠ², ΠΎΡ‚Π»ΠΈΡ‡Π°ΡŽΡ‚ΡΡ, ΠΎΠ΄Π½Π°ΠΊΠΎ срСдниС значСния ΠΈΡ… прироста (Ξ”) Π½Π΅ ΠΈΠΌΠ΅Π»ΠΈ статистичСски достовСрных Ρ€Π°Π·Π»ΠΈΡ‡ΠΈΠΉ. По Ρ€Π΅Π·ΡƒΠ»ΡŒΡ‚Π°Ρ‚Π°ΠΌ коррСляционного Π°Π½Π°Π»ΠΈΠ·Π° выявлСна сильная ΠΏΠΎΠ»ΠΎΠΆΠΈΡ‚Π΅Π»ΡŒΠ½Π°Ρ статистичСски достовСрная взаимосвязь ΠΌΠ΅ΠΆΠ΄Ρƒ Ξ” Π‘ΠœΠ•Π’Π΄ ΠΈ Ξ” ΠœΠ•Π’Π΄ (Π΄ΠΎ сСанса r = 0,74, послС сСанса r = 0,79, ΠΏΠΎ всСму массиву Π΄Π°Π½Π½Ρ‹Ρ… r = 0,77, Β Ρ€<0,01), которая ΠΈΠΌΠ΅Π΅Ρ‚ Ρ…ΠΎΡ€ΠΎΡˆΡƒΡŽ ΡΠΎΠ³Π»Π°ΡΠΎΠ²Π°Π½Π½ΠΎΡΡ‚ΡŒ ΠΏΠΎ Π°Π½Π°Π»ΠΈΠ·Ρƒ Π‘Π»ΡΠ½Π΄Π°β€“ΠΠ»ΡŒΡ‚ΠΌΠ°Π½Π°, ΠΎ Ρ‡Π΅ΠΌ ΡΠ²ΠΈΠ΄Π΅Ρ‚Π΅Π»ΡŒΡΡ‚Π²ΡƒΠ΅Ρ‚ Ρ‚ΠΎ, Ρ‡Ρ‚ΠΎ Β Π±ΠΎΠ»Π΅Π΅ 95% Π·Π½Π°Ρ‡Π΅Π½ΠΈΠΉΒ  Π½Π°Ρ…ΠΎΠ΄ΠΈΠ»ΠΈΡΡŒ Π² ΠΏΡ€Π΅Π΄Π΅Π»Π°Ρ…Β  Β± 1,96 SD ΠΎΡ‚ срСднСй Ρ€Π°Π·Π½ΠΈΡ†Ρ‹. ΠœΠ΅Ρ‚ΠΎΠ΄ ΠΏΠΎΠ±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠΉ спиромСтрии ΠΏΠΎΠΊΠ°Π·Π°Π» Ρ…ΠΎΡ€ΠΎΡˆΡƒΡŽ Π΄ΠΈΠ°Π³Π½ΠΎΡΡ‚ΠΈΡ‡Π΅ΡΠΊΡƒΡŽ Ρ‚ΠΎΡ‡Π½ΠΎΡΡ‚ΡŒ ΠΏΡ€ΠΈ ROC-Π°Π½Π°Π»ΠΈΠ·Π΅ (Ρ‡ΡƒΠ²ΡΡ‚Π²ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΡΡ‚ΡŒ 87%, ΡΠΏΠ΅Ρ†ΠΈΡ„ΠΈΡ‡Π½ΠΎΡΡ‚ΡŒ 85%, ΠΏΠ»ΠΎΡ‰Π°Π΄ΡŒ ΠΏΠΎΠ΄ ΠΊΡ€ΠΈΠ²ΠΎΠΉ (AUC) 0,8 (95% Π”Π˜: [0,76;0,83]), Ρ€<0,001). ΠžΡ‚ΠΊΠ°Π· ΠΎΡ‚ ΠΏΡ€ΠΎΡ†Π΅Π΄ΡƒΡ€Ρ‹ Ρ‡Π°Ρ‰Π΅ наблюдали ΠΏΡ€ΠΈ использовании ΠΌΠ΅Ρ‚ΠΎΠ΄Π° ΡƒΠ»ΡŒΡ‚Ρ€Π°Π·Π²ΡƒΠΊΠΎΠ²ΠΎΠΉ спирографии.Π—Π°ΠΊΠ»ΡŽΡ‡Π΅Π½ΠΈΠ΅. ΠŸΡ€ΠΈΡ€ΠΎΡΡ‚ показатСля Смкости Π²Π΄ΠΎΡ…Π°, ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½Π½ΠΎΠΉ с ΠΏΠΎΠΌΠΎΡ‰ΡŒΡŽ ΠΏΠΎΠ±ΡƒΠ΄ΠΈΡ‚Π΅Π»ΡŒΠ½ΠΎΠ³ΠΎ спиромСтра, Ρ…ΠΎΡ€ΠΎΡˆΠΎ согласуСтся с ΠΈΠ·ΠΌΠ΅Ρ€Π΅Π½Π½Ρ‹ΠΌ ΠΌΠ΅Ρ‚ΠΎΠ΄ΠΎΠΌ ΡƒΠ»ΡŒΡ‚Ρ€Π°Π·Π²ΡƒΠΊΠΎΠ²ΠΎΠΉΒ  спирографии ΠΈ ΠΌΠΎΠΆΠ΅Ρ‚ ΠΈΡΠΏΠΎΠ»ΡŒΠ·ΠΎΠ²Π°Ρ‚ΡŒΡΡ для ΠΎΡ†Π΅Π½ΠΊΠΈ эффСктивности Ρ€Π΅Π°Π±ΠΈΠ»ΠΈΡ‚Π°Ρ†ΠΈΠΎΠ½Π½Ρ‹Ρ… мСроприятий Π² Ρ€Π°Π½Π½Π΅ΠΌ послСопСрационном ΠΏΠ΅Ρ€ΠΈΠΎΠ΄Π΅ Ρƒ кардиохирургичСских ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ²

    Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists

    Get PDF
    It has now been demonstrated that the ΞΌ, Ξ΄(1), Ξ΄(2), and ΞΊ(1) opioid receptor (OR) agonists represent the most promising group of opioids for the creation of drugs enhancing cardiac tolerance to the detrimental effects of ischemia/reperfusion (I/R). Opioids are able to prevent necrosis and apoptosis of cardiomyocytes during I/R and improve cardiac contractility in the reperfusion period. The OR agonists exert an infarct‐reducing effect with prophylactic administration and prevent reperfusion‐induced cardiomyocyte death when ischemic injury of heart has already occurred; that is, opioids can mimic preconditioning and postconditioning phenomena. Furthermore, opioids are also effective in preventing ischemia‐induced arrhythmias

    Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection

    No full text
    Rodent autonomous parvoviruses (PVs) are endowed with oncotropic properties and represent virotherapeutics with inherent oncolytic features. This work aimed to evaluate the capacity of Minute Virus of Mice (MVMp) to act as an adjuvant stimulating a mouse glioblastoma-specific immune response. MVMp was shown to induce cell death through apoptosis in glioma GL261 cells. Antigen-presenting cells (APCs) provide the initial cue for innate and adaptive immune responses, and thus MVMp-infected GL261 cells were tested for their ability to activate dendritic cells (DCs) and microglia (MG), two distinct cell types that are able to act as APCs. MG and discrete DC subsets were activated after co-culture with MVMp-infected glioma GL261 cells, as evidenced by upregulation of specific activation markers (CD80, CD86) and release of proinflammatory cytokines (tumor necrosis factor-a and interleukin-6). The in vivo analysis of immunodeficient and immunocompetent mice revealed a clear difference in their susceptibility to MVMp-mediated tumor suppression. Immunocompetent mice were fully protected from tumor outgrowth of GL261 cells infected ex vivo with MVMp. In contrast, immunodeficient animals were less competent for MVMp-dependent tumor inhibition, with only 20% of the recipients being protected, arguing for an additional immune component to allow full tumor suppression. In keeping with this conclusion, immunocompetent mice engrafted with MVMp-infected glioma cells developed a level of anti-tumor immunity with isolated splenocytes producing elevated levels of interferon-gamma. In rechallenge experiments using uninfected GL261 cells, we could show complete protection against the tumor, arguing for the induction of a T-cell-mediated, tumor-specific, long-term memory response. These findings indicate that the anticancer effect of PVs can be traced back not only for their direct oncolytic effect, but also to their ability to break tumor tolerance

    New materials for adsorption heat transformation and storage

    No full text
    Great current progress in the materials science offers an enormous choice of novel adsorbents which may be promising for transformation and storage of low temperature heat, e.g. from renewable heat sources. This paper gives an overview of recent trends and achievements in this field. We consider possible optimization of zeolites by dealumination, further development on aluminophosphates, composites salt in porous host matrice and metal-organic frameworks which are currently receiving the largest share of scientific attention. The particular attention is focused on the chemical nano-tailoring and tunable adsorption behavior of these materials to satisfy the demands of appropriate heat transformation cycles. We hope that this review will give new impact on target-oriented research on the novel adsorbents for heat transformation and storage

    Human Retrotransposons and the Global Shutdown of Homeostatic Innate Immunity by Oncolytic Parvovirus H-1PV in Pancreatic Cancer

    No full text
    Although the oncolytic parvovirus H-1PV has entered clinical trials, predicting therapeutic success remains challenging. We investigated whether the antiviral state in tumor cells determines the parvoviral oncolytic efficacy. The interferon/interferon-stimulated genes (IFN/ISG)-circuit and its major configurator, human endogenous retroviruses (HERVs), were evaluated using qRT-PCR, ELISA, Western blot, and RNA-Seq techniques. In pancreatic cancer cell lines, H-1PV caused a late global shutdown of innate immunity, whereby the concomitant inhibition of HERVs and IFN/ISGs was co-regulatory rather than causative. The growth-inhibitory IC50 doses correlated with the power of suppression but not with absolute ISG levels. Moreover, H-1PV was not sensitive to exogenous IFN despite upregulated antiviral ISGs. Such resistance questioned the biological necessity of the oncotropic ISG-shutdown, which instead might represent a surrogate marker for personalized oncolytic efficacy. The disabled antiviral homeostasis may modify the activity of other viruses, as demonstrated by the reemergence of endogenous AluY-retrotransposons. This way of suppression may compromise the interferogenicity of drugs having gemcitabine-like mechanisms of action. This shortcoming in immunogenic cell death induction is however amendable by immune cells which release IFN in response to H-1PV

    The cryopuncture method in treating patients with psoriatic arthritis

    Get PDF
    ΠœΠ΅Ρ‚ΠΎΠ΄ ΠΊΡ€ΠΈΠΎΠΏΡƒΠ½ΠΊΡ‚ΡƒΡ€Ρ‹ ΠΏΡ€Π΅Π΄Π»ΠΎΠΆΠ΅Π½ для лСчСния ΠΏΠ°Ρ†ΠΈΠ΅Π½Ρ‚ΠΎΠ² с псориатичСским Π°Ρ€Ρ‚Ρ€ΠΈΡ‚ΠΎΠΌ. ИспользованиС ΠΊΡ€ΠΈΠΎΠΏΡƒΠ½ΠΊΡ‚ΡƒΡ€Ρ‹ способствуСт ΡƒΠ»ΡƒΡ‡ΡˆΠ΅Π½ΠΈΡŽ тСчСния заболСвания ΠΈ ΡƒΠΌΠ΅Π½ΡŒΡˆΠ°Π΅Ρ‚ Π±ΠΎΠ»Π΅Π²ΠΎΠΉ синдром. Method of cryopuncture therapy were proposed to treat patients with psoriatic arthritis. The use of cryotherapy contributes to improving the course of the disease, decreasing the pain syndrome
    corecore